Explore how thoughtful, well-supported transportation strategies can reduce barriers, enhance participant retention, and strengthen the overall success of clinical trials.
INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Human Abuse Potential: Participant Safety
Explore how clinical staffing, monitoring equipment, and structured safety oversight support the safe conduct of Human Abuse Potential studies, including approaches to adverse event management.
-
Retention Through Intention — Designing Truly Patient-Centric Trials
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
-
Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy
Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.
-
Electronic Body Maps Drive Standardization Across Top-10 Pharma
Learn how a top-10 pharmaceutical client was able to "fundamentally transform the way they execute clinical trials" with the digitization and standardization of pain maps in a diabetic polyneuropathy trial.
-
Evaluating Patient Recruitment Partners When Enrollment Isn't Going To Plan8/18/2025
Timely and effective patient recruitment remains one of the greatest challenges in clinical research, with success depending on optimizing patient quality and sustained engagement support.
-
Avoid The Wrecking Ball: Targeted Solutions For Struggling Trials9/30/2025
In this presentation, our expert panel introduces the concept of scaffolding — a targeted reinforcement strategy designed to strengthen trials from the inside out.
-
Enhancing Investigator Training And Communication During COVID-196/26/2024
Centralizing all trial-related information, enabling seamless interaction and global team coordination through Scout Academy.
-
Clinical, Commercial Packaging: Delivering Next-Gen Therapies4/7/2026
See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.
-
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
-
Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.
-
Complex oncology trials require deep science, regulatory expertise, and coordination. See how integrated teams and adaptive designs speed startup, protect patients, and scale.
-
Medidata Adjudicate is part of the Medidata Clinical Cloud™, and offers a cloud-based, end-to-end solution, with easily configurable modules enabling quick setup to manage endpoint adjudication in clinical trials. Medidata Adjudicate supports investigator sites, sponsors, CROs, data managers, and the CEC in collecting, managing, organizing, adjudicating and submitting clinical endpoint data.